Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 526524, 9 pages
http://dx.doi.org/10.1155/2015/526524
Review Article

Functional Roles of Calreticulin in Cancer Biology

Yi-Chien Lu,1,2,3 Wen-Chin Weng,1,4 and Hsinyu Lee1,5,6,7

1Department of Life Science, National Taiwan University, Taipei 106, Taiwan
2Department of Radiology, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan
3Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
4Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 100, Taiwan
5Research Center for Developmental Biology and Regenerative Medicine, National Taiwan University, Taipei 116, Taiwan
6Center for Biotechnology, National Taiwan University, Taipei 116, Taiwan
7Angiogenesis Research Center, National Taiwan University, Taipei 116, Taiwan

Received 19 December 2014; Revised 4 March 2015; Accepted 5 March 2015

Academic Editor: Marlene Benchimol

Copyright © 2015 Yi-Chien Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Michalak, E. F. Corbett, N. Mesaeli, K. Nakamura, and M. Opas, “Calreticulin: one protein, one gene, many functions,” Biochemical Journal, vol. 344, no. 2, pp. 281–292, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Michalak, J. M. R. Parker, and M. Opas, “Ca2+ signaling and calcium binding chaperones of the endoplasmic reticulum,” Cell Calcium, vol. 32, no. 5-6, pp. 269–278, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. M. V. Rojiani, “In vitro interaction of a polypeptide homologous to human Ro/SS-A antigen (Calreticulin) with a highly conserved amino acid sequence in the cytoplasmic domain of integrin α subunits,” Biochemistry, vol. 30, no. 41, pp. 9859–9866, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Burns, B. Duggan, E. A. Atkinson et al., “Modulation of gene expression by calreticulin binding to the glucocorticoid receptor,” Nature, vol. 367, no. 6462, pp. 476–480, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Martin, J. Groenendyk, S. S. Steiner et al., “Identification by mutational analysis of amino acid residues essential in the chaperone function of calreticulin,” The Journal of Biological Chemistry, vol. 281, no. 4, pp. 2338–2346, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. K.-H. Krause and M. Michalak, “Calreticulin,” Cell, vol. 88, no. 4, pp. 439–443, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Baksh and M. Michalak, “Expression of calreticulin in Escherichia-coli and identification of its Ca2+ binding domains,” The Journal of Biological Chemistry, vol. 266, no. 32, pp. 21458–21465, 1991. View at Google Scholar · View at Scopus
  8. L. W. Tjoelker, C. E. Seyfried, R. L. Eddy Jr. et al., “Human, mouse, and rat calnexin cDNA cloning: identification of potential calcium binding motifs and gene localization to human chromosome 5,” Biochemistry, vol. 33, no. 11, pp. 3229–3236, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Nakamura, A. Zuppini, S. Arnaudeau et al., “Functional specialization of calreticulin domains,” The Journal of Cell Biology, vol. 154, no. 5, pp. 961–972, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. E. F. Corbett, K. Oikawa, P. Francois et al., “Ca2+ regulation of interactions between endoplasmic reticulum chaperones,” The Journal of Biological Chemistry, vol. 274, no. 10, pp. 6203–6211, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Michalak, R. E. Milner, K. Burns, and M. Opas, “Calreticulin,” Biochemical Journal, vol. 285, no. 3, pp. 681–692, 1992. View at Google Scholar · View at Scopus
  12. T. K. White, Q. Zhu, and M. L. Tanzer, “Cell surface calreticulin is a putative mannoside lectin which triggers mouse melanoma cell spreading,” The Journal of Biological Chemistry, vol. 270, no. 27, pp. 15926–15929, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Afshar, B. E. Black, and B. M. Paschal, “Retrotranslocation of the chaperone calreticulin from the endoplasmic reticulum lumen to the cytosol,” Molecular and Cellular Biology, vol. 25, no. 20, pp. 8844–8853, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. C. A. Labriola, I. L. Conte, M. L. Medus, A. J. Parodi, and J. J. Caramelo, “Endoplasmic reticulum calcium regulates the retrotranslocation of Trypanosoma cruzi calreticulin to the cytosol,” PLoS ONE, vol. 5, no. 10, Article ID e13141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. G. Coppolino, M. J. Woodside, N. Demaurex, S. Grinstein, R. St-Arnaud, and S. Dedhar, “Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion,” Nature, vol. 386, no. 6627, pp. 843–847, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Dedhar, “Novel functions for calreticulin: interaction with integrins and modulation of gene expression?” Trends in Biochemical Sciences, vol. 19, no. 7, pp. 269–271, 1994. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Y. Leung-Hagesteijn, K. Milankov, M. Michalak, J. Wilkins, and S. Dedhar, “Cell attachment to extracellular matrix substrates is inhibited upon downregulation of expression of calreticulin, an intracellular integrin α-subunit-binding protein,” Journal of Cell Science, vol. 107, no. 3, pp. 589–600, 1994. View at Google Scholar · View at Scopus
  18. M. Raghavan, S. J. Wijeyesakere, L. R. Peters, and N. del Cid, “Calreticulin in the immune system: ins and outs,” Trends in Immunology, vol. 34, no. 1, pp. 13–21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Labriola, J. J. Cazzulo, and A. J. Parodi, “Trypanosoma cruzi calreticulin is a lectin that binds monoglucosylated oligosaccharides but not protein moieties of glycoproteins,” Molecular Biology of the Cell, vol. 10, no. 5, pp. 1381–1394, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Zapun, N. J. Darby, D. C. Tessier, M. Michalak, J. J. M. Bergeron, and D. Y. Thomas, “Enhanced catalysis of ribonuclease B folding by the interaction of calnexin or calreticulin with ERp57,” The Journal of Biological Chemistry, vol. 273, no. 11, pp. 6009–6012, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Vassilakos, M. Michalak, M. A. Lehrman, and D. B. Williams, “Oligosaccharide binding characteristics of the molecular chaperones calnexin and calreticulin,” Biochemistry, vol. 37, no. 10, pp. 3480–3490, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. R. G. Spiro, Q. Zhu, V. Bhoyroo, and H.-D. Söling, “Definition of the lectin-like properties of the molecular chaperone, calreticulin, and demonstration of its copurification with endomannosidase from rat liver Golgi,” The Journal of Biological Chemistry, vol. 271, no. 19, pp. 11588–11594, 1996. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Pozzan, R. Rizzuto, P. Volpe, and J. Meldolesi, “Molecular and cellular physiology of intracellular calcium stores,” Physiological Reviews, vol. 74, no. 3, pp. 595–636, 1994. View at Google Scholar · View at Scopus
  24. J. Meldolesi and T. Pozzan, “The endoplasmic reticulum Ca2+ store: a view from the lumen,” Trends in Biochemical Sciences, vol. 23, no. 1, pp. 10–14, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Michalak, J. Groenendyk, E. Szabo, L. I. Gold, and M. Opas, “Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum,” Biochemical Journal, vol. 417, no. 3, pp. 651–666, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Araki and K. Nagata, “Protein folding and quality control in the ER,” Cold Spring Harbor Perspectives in Biology, vol. 3, no. 11, Article ID a007526, 2011. View at Publisher · View at Google Scholar
  27. J.-P. Lièvremont, R. Rizzuto, L. Hendershot, and J. Meldolesi, “BiP, a major chaperone protein of the endoplasmic reticulum lumen, plays a direct and important role in the storage of the rapidly exchanging pool of Ca2+,” The Journal of Biological Chemistry, vol. 272, no. 49, pp. 30873–30879, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Bastianutto, E. Clementi, F. Codazzi et al., “Overexpression of calreticulin increases the Ca2+ capacity of rapidly exchanging Ca2+ stores and reveals aspects of their lumenal microenvironment and function,” The Journal of Cell Biology, vol. 130, no. 4, pp. 847–855, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Mery, N. Mesaeli, M. Michalak, M. Opas, D. P. Lew, and K. H. Krause, “Overexpression of calreticulin increases intracellular Ca2+ storage and decreases store-operated Ca2+ influx,” The Journal of Biological Chemistry, vol. 271, no. 16, pp. 9332–9339, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Lynch, L. Guo, P. Gelebart et al., “Calreticulin signals upstream of calcineurin and MEF2C in a critical Ca2+-dependent signaling cascade,” The Journal of Cell Biology, vol. 170, no. 1, pp. 37–47, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Guo, K. Nakamura, J. Lynch et al., “Cardiac-specific expression of calcineurin reverses embryonic lethality in calreticulin-deficient mouse,” The Journal of Biological Chemistry, vol. 277, no. 52, pp. 50776–50779, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Bibi, N. K. Agarwal, G. H. Dihazi et al., “Calreticulin is crucial for calcium homeostasis mediated adaptation and survival of thick ascending limb of Henle's loop cells under osmotic stress,” The International Journal of Biochemistry & Cell Biology, vol. 43, no. 8, pp. 1187–1197, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Szabo, Y. Qiu, S. Baksh, M. Michalak, and M. Opas, “Calreticulin inhibits commitment to adipocyte differentiation,” The Journal of Cell Biology, vol. 182, no. 1, pp. 103–116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Villagomez, E. Szabo, A. Podcheko, T. Feng, S. Papp, and M. Opas, “Calreticulin and focal-contact-dependent adhesion,” Biochemistry and Cell Biology, vol. 87, no. 4, pp. 545–556, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. M. P. Fadel, E. Dziak, C.-M. Lo et al., “Calreticulin affects focal contact-dependent but not close contact-dependent cell-substratum adhesion,” Journal of Biological Chemistry, vol. 274, no. 21, pp. 15085–15094, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. C. Lu, C. N. Chen, B. Wang et al., “Changes in tumor growth and metastatic capacities of J82 human bladder cancer cells suppressed by down-regulation of calreticulin expression,” The American Journal of Pathology, vol. 179, no. 3, pp. 1425–1433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Papp, E. Szabo, H. Kim, C. A. McCulloch, and M. Opas, “Kinase-dependent adhesion to fibronectin: regulation by calreticulin,” Experimental Cell Research, vol. 314, no. 6, pp. 1313–1326, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Opas, M. Szewczenko-Pawlikowski, G. K. Jass, N. Mesaeli, and M. Michalak, “Calreticulin modulates cell adhesiveness via regulation of vinculin expression,” The Journal of Cell Biology, vol. 135, no. 6, pp. 1913–1923, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Papp, M. P. Fadel, H. Kim, C. A. McCulloch, and M. Opas, “Calreticulin affects fibronectin-based cell-substratum adhesion via the regulation of c-Src activity,” The Journal of Biological Chemistry, vol. 282, no. 22, pp. 16585–16598, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Dedhar, P. S. Rennie, M. Shago et al., “Inhibition of nuclear hormone receptor activity by calreticulin,” Nature, vol. 367, no. 6462, pp. 480–483, 1994. View at Publisher · View at Google Scholar · View at Scopus
  41. M. G. Coppolino and S. Dedhar, “Ligand-specific, transient interaction between integrins and calreticulin during cell adhesion to extracellular matrix proteins is dependent upon phosphorylation/dephosphorylation events,” Biochemical Journal, vol. 340, no. 1, pp. 41–50, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Nickenig, F. Michaelsen, C. Müller et al., “Destabilization of AT1 receptor mRNA by calreticulin,” Circulation Research, vol. 90, no. 1, pp. 53–58, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. W.-F. Chiang, T.-Z. Hwang, T.-C. Hour et al., “Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma,” Oral Oncology, vol. 49, no. 6, pp. 534–541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. X.-L. Du, H. Hu, D.-C. Lin et al., “Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma,” Journal of Molecular Medicine (Berl), vol. 85, no. 8, pp. 863–875, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. Z.-M. Lwin, C. Guo, A. Salim et al., “Clinicopathological significance of calreticulin in breast invasive ductal carcinoma,” Modern Pathology, vol. 23, no. 12, pp. 1559–1566, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Chahed, M. Kabbage, L. Ehret-Sabatier et al., “Expression of fibrinogen E-fragment and fibrin E-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: the two-dimensional electrophoresis and MALDI-TOF-mass spectrometry analyses,” International Journal of Oncology, vol. 27, no. 5, pp. 1425–1431, 2005. View at Google Scholar · View at Scopus
  47. L. Bini, B. Magi, B. Marzocchi et al., “Protein expression profiles in human breast ductal carcinoma and histologically normal tissue,” Electrophoresis, vol. 18, no. 15, pp. 2832–2841, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. W. Sheng, C. Chen, M. Dong et al., “Overexpression of calreticulin contributes to the development and progression of pancreatic cancer,” Journal of Cellular Physiology, vol. 229, no. 7, pp. 887–897, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. C.-N. Chen, C.-C. Chang, T.-E. Su et al., “Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer,” Annals of Surgical Oncology, vol. 16, no. 2, pp. 524–533, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. P. Alfonso, A. Núñez, J. Madoz-Gurpide, L. Lombardia, L. Sánchez, and J. I. Casal, “Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis,” Proteomics, vol. 5, no. 10, pp. 2602–2611, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Minami, R. Nagashio, J. Ueda et al., “Detection of tumor-associated antigens in culture supernatants using autoantibodies in sera from patients with bladder cancer,” Biomedical Research, vol. 35, no. 1, pp. 25–35, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Kageyama, T. Isono, H. Iwaki et al., “Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine,” Clinical Chemistry, vol. 50, no. 5, pp. 857–866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Kageyama, T. Isono, S. Matsuda et al., “Urinary calreticulin in the diagnosis of bladder urothelial carcinoma,” International Journal of Urology, vol. 16, no. 5, pp. 481–486, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Alaiya, U. Roblick, L. Egevad et al., “Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma,” Analytical Cellular Pathology, vol. 21, no. 1, pp. 1–9, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Hellman, A. A. Alaiya, K. Schedvins, W. Steinberg, A.-C. Hellström, and G. Auer, “Protein expression patterns in primary carcinoma of the vagina,” British Journal of Cancer, vol. 91, no. 2, pp. 319–326, 2004. View at Google Scholar · View at Scopus
  56. O. Vaksman, B. Davidson, C. Tropé, and R. Reich, “Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases,” Human Pathology, vol. 44, no. 12, pp. 2677–2683, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. W. M. Hsu, F. J. Hsieh, Y. M. Jeng et al., “Calreticulin expression in neuroblastoma—a novel independent prognostic factor,” Annals of Oncology, vol. 16, no. 2, pp. 314–321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Totary-Jain, T. Naveh-Many, Y. Riahi, N. Kaiser, J. Eckel, and S. Sasson, “Calreticulin destabilizes glucose transporter-1 mRNA in vascular endothelial and smooth muscle cells under high-glucose conditions,” Circulation Research, vol. 97, no. 10, pp. 1001–1008, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Qiu and M. Michalak, “Transcriptional control of the calreticulin gene in health and disease,” The International Journal of Biochemistry & Cell Biology, vol. 41, no. 3, pp. 531–538, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Q. Nguyen, J. D. Capra, and R. D. Sontheimer, “Calreticulin is transcriptionally upregulated by heat shock, calcium and heavy metals,” Molecular Immunology, vol. 33, no. 4-5, pp. 379–386, 1996. View at Publisher · View at Google Scholar · View at Scopus
  61. C. Vera, V. Tapia, K. Kohan et al., “Nerve growth factor induces the expression of chaperone protein calreticulin in human epithelial ovarian cells,” Hormone and Metabolic Research, vol. 44, no. 8, pp. 639–643, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. Y.-Y. Shih, A. Nakagawara, H. Lee et al., “Calreticulin mediates nerve growth factor-induced neuronal differentiation,” Journal of Molecular Neuroscience, vol. 47, no. 3, pp. 571–581, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Zamanian, A. Veerakumarasivam, S. Abdullah, and R. Rosli, “Calreticulin and cancer,” Pathology & Oncology Research, vol. 19, no. 2, pp. 149–154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. H.-H. Chang, H. Lee, M.-K. Hu et al., “Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma,” Clinical Cancer Research, vol. 16, no. 17, pp. 4411–4420, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Klampfl, H. Gisslinger, A. S. Harutyunyan et al., “Somatic mutations of calreticulin in myeloproliferative neoplasms,” The New England Journal of Medicine, vol. 369, no. 25, pp. 2379–2390, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Nangalia, C. E. Massie, E. J. Baxter et al., “Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2,” The New England Journal of Medicine, vol. 369, no. 25, pp. 2391–2405, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. C. James, V. Ugo, J.-P. Le Couédic et al., “A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera,” Nature, vol. 434, no. 7037, pp. 1144–1148, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Kralovics, F. Passamonti, A. S. Buser et al., “A gain-of-function mutation of JAK2 in myeloproliferative disorders,” The New England Journal of Medicine, vol. 352, no. 17, pp. 1779–1790, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. C. Sun, S. Zhang, and J. Li, “Calreticulin gene mutations in myeloproliferative neoplasms without Janus kinase 2 mutations,” Leukemia & Lymphoma, 2014. View at Publisher · View at Google Scholar
  70. V. R. Wiersma, M. Michalak, T. M. Abdullah, E. Bremer, and P. Eggleton, “Mechanisms of translocation of ER chaperones to the cell surface and immunomodulatory roles in cancer and autoimmunity,” Frontiers in Oncology, vol. 5, article 7, 2015. View at Publisher · View at Google Scholar
  71. S. J. Gardai, K. A. McPhillips, S. C. Frasch et al., “Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte,” Cell, vol. 123, no. 2, pp. 321–334, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Obeid, A. Tesniere, F. Ghiringhelli et al., “Calreticulin exposure dictates the immunogenicity of cancer cell death,” Nature Medicine, vol. 13, no. 1, pp. 54–61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. M. P. Chao, S. Jaiswal, R. Weissman-Tsukamoto et al., “Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47,” Science Translational Medicine, vol. 2, no. 63, pp. 63–94, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. C. Clarke and M. J. Smyth, “Calreticulin exposure increases cancer immunogenicity,” Nature Biotechnology, vol. 25, no. 2, pp. 192–193, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. T. Panaretakis, O. Kepp, U. Brockmeier et al., “Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death,” The EMBO Journal, vol. 28, no. 5, pp. 578–590, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Panaretakis, N. Joza, N. Modjtahedi et al., “The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death,” Cell Death and Differentiation, vol. 15, no. 9, pp. 1499–1509, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Obeid, “ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin,” Journal of Immunology, vol. 181, no. 4, pp. 2533–2543, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. L. Zitvogel, O. Kepp, L. Senovilla, L. Menger, N. Chaput, and G. Kroemer, “Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway,” Clinical Cancer Research, vol. 16, no. 12, pp. 3100–3104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. L. R. Peters and M. Raghavan, “Endoplasmic reticulum calcium depletion impacts chaperone secretion, innate immunity, and phagocytic uptake of cells,” Journal of Immunology, vol. 187, no. 2, pp. 919–931, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Tufi, T. Panaretakis, K. Bianchi et al., “Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin,” Cell Death & Differentiation, vol. 15, no. 2, pp. 274–282, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Sene, D. Chin-Yee, and R. S. Apte, “Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye,” Trends in Molecular Medicine, vol. 21, no. 1, pp. 43–51, 2015. View at Publisher · View at Google Scholar
  82. D. R. Senger, L. van de Water, L. F. Brown et al., “Vascular permeability factor (VPF, VEGF) in tumor biology,” Cancer and Metastasis Reviews, vol. 12, no. 3-4, pp. 303–324, 1993. View at Publisher · View at Google Scholar · View at Scopus
  83. X. Liang, F. Xu, X. Li, C. Ma, Y. Zhang, and W. Xu, “VEGF signal system: the application of antiangiogenesis,” Current Medicinal Chemistry, vol. 21, no. 7, pp. 894–910, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. E. Roberts, D. A. F. Cossigny, and G. M. Y. Quan, “The role of vascular endothelial growth factor in metastatic prostate cancer to the skeleton,” Prostate Cancer, vol. 2013, Article ID 418340, 8 pages, 2013. View at Publisher · View at Google Scholar
  85. M. Alur, M. M. Nguyen, S. E. Eggener et al., “Suppressive roles of calreticulin in prostate cancer growth and metastasis,” The American Journal of Pathology, vol. 175, no. 2, pp. 882–890, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. Q. Shu, W. Li, H. Li, and G. Sun, “Vasostatin inhibits VEGF-induced endothelial cell proliferation, tube formation and induces cell apoptosis under oxygen deprivation,” International Journal of Molecular Sciences, vol. 15, no. 4, pp. 6019–6030, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. W.-C. Weng, K.-H. Lin, P.-Y. Wu et al., “Calreticulin regulates VEGF-A in neuroblastoma cells,” Molecular Neurobiology, 2014. View at Publisher · View at Google Scholar
  88. G. M. Brodeur, “Neuroblastoma: biological insights into a clinical enigma,” Nature Reviews Cancer, vol. 3, no. 3, pp. 203–216, 2003. View at Publisher · View at Google Scholar · View at Scopus
  89. H.-H. Chang and W.-M. Hsu, “Neuroblastoma—a model disease for childhood cancer,” Journal of the Formosan Medical Association, vol. 109, no. 8, pp. 555–557, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. J. M. Maris, M. D. Hogarty, R. Bagatell, and S. L. Cohn, “Neuroblastoma,” The Lancet, vol. 369, no. 9579, pp. 2106–2120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. M. A. Israel, “Disordered differentiation as a target for novel approaches to the treatment of neuroblastoma,” Cancer, vol. 71, no. 10, pp. 3310–3313, 1993. View at Publisher · View at Google Scholar · View at Scopus
  92. R. Ijiri, Y. Tanaka, K. Kato et al., “Clinicopathologic study of mass-screened neuroblastoma with special emphasis on untreated observed cases: a possible histologic clue to tumor regression,” The American Journal of Surgical Pathology, vol. 24, no. 6, pp. 807–815, 2000. View at Publisher · View at Google Scholar · View at Scopus
  93. H. Nishihira, Y. Toyoda, Y. Tanaka et al., “Natural course of neuroblastoma detected by mass screening: a 5-year prospective study at a single institution,” Journal of Clinical Oncology, vol. 18, no. 16, pp. 3012–3017, 2000. View at Google Scholar · View at Scopus
  94. N. Sidell, A. Altman, M. R. Haussler, and R. C. Seeger, “Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines,” Experimental Cell Research, vol. 148, no. 1, pp. 21–30, 1983. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Nakagawara, M. Arima-Nakagawara, N. J. Scavarda, C. G. Azar, A. B. Cantor, and G. M. Brodeur, “Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma,” The New England Journal of Medicine, vol. 328, no. 12, pp. 847–854, 1993. View at Publisher · View at Google Scholar · View at Scopus
  96. J. C. Hoehner, C. Gestblom, L. Olsen, and S. Påhlman, “Spatial association of apoptosis-related gene expression and cellular death in clinical neuroblastoma,” British Journal of Cancer, vol. 75, no. 8, pp. 1185–1194, 1997. View at Publisher · View at Google Scholar · View at Scopus
  97. F. Rauch, J. Prud'Homme, A. Arabian, S. Dedhar, and R. St-Arnaud, “Heart, brain, and body wall defects in mice lacking calreticulin,” Experimental Cell Research, vol. 256, no. 1, pp. 105–111, 2000. View at Publisher · View at Google Scholar · View at Scopus
  98. G. Xiao, T.-F. Chung, H. Y. Pyun, R. E. Fine, and R. J. Johnson, “KDEL proteins are found on the surface of NG108-15 cells,” Molecular Brain Research, vol. 72, no. 2, pp. 121–128, 1999. View at Publisher · View at Google Scholar · View at Scopus
  99. M. Wu, X. Bai, G. Xu et al., “Proteome analysis of human androgen-independent prostate cancer cell lines: variable metastatic potentials correlated with vimentin expression,” Proteomics, vol. 7, no. 12, pp. 1973–1983, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Coppolino, C. Leung-Hagesteijn, S. Dedhar, and J. Wilkins, “Inducible Interaction of Integrin α2β1 with calreticulin: dependence on the activation state of the integrin,” Journal of Biological Chemistry, vol. 270, no. 39, pp. 23132–23138, 1995. View at Publisher · View at Google Scholar · View at Scopus
  101. M. G. Coppolino and S. Dedhar, “Ligand-specific, transient interaction between integrins and calreticulin during cell adhesion to extracellular matrix proteins is dependent upon phosphorylation/dephosphorylation events,” Biochemical Journal, vol. 340, part 1, pp. 41–50, 1999. View at Publisher · View at Google Scholar · View at Scopus
  102. Y. Ihara, Y. Inai, and M. Ikezaki, “Alteration of integrin-dependent adhesion and signaling in EMT-like MDCK cells established through overexpression of calreticulin,” Journal of Cellular Biochemistry, vol. 112, no. 9, pp. 2518–2528, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. E. Szabo, S. Papp, and M. Opas, “Differential calreticulin expression affects focal contacts via the calmodulin/CaMK II pathway,” Journal of Cellular Physiology, vol. 213, no. 1, pp. 269–277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. S. Goicoechea, A. W. Orr, M. A. Pallero, P. Eggleton, and J. E. Murphy-Ullrich, “Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin,” The Journal of Biological Chemistry, vol. 275, no. 46, pp. 36358–36368, 2000. View at Publisher · View at Google Scholar · View at Scopus
  105. E. M. Morse, N. N. Brahme, and D. A. Calderwood, “Integrin cytoplasmic tail interactions,” Biochemistry, vol. 53, no. 5, pp. 810–820, 2014. View at Publisher · View at Google Scholar · View at Scopus
  106. Y.-C. Lu, C.-N. Chen, C.-Y. Chu et al., “Calreticulin activates β1 integrin via fucosylation by fucosyltransferase 1 in J82 human bladder cancer cells,” The Biochemical Journal, vol. 460, no. 1, pp. 69–78, 2014. View at Publisher · View at Google Scholar · View at Scopus
  107. C. Ciobanasu, B. Faivre, and C. le Clainche, “Integrating actin dynamics, mechanotransduction and integrin activation: the multiple functions of actin binding proteins in focal adhesions,” European Journal of Cell Biology, vol. 92, no. 10-11, pp. 339–348, 2013. View at Publisher · View at Google Scholar · View at Scopus